BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24649127)

  • 1. Nestin regulates epithelial-mesenchymal transition marker expression in pancreatic ductal adenocarcinoma cell lines.
    Hagio M; Matsuda Y; Suzuki T; Ishiwata T
    Mol Clin Oncol; 2013 Jan; 1(1):83-87. PubMed ID: 24649127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer.
    Su HT; Weng CC; Hsiao PJ; Chen LH; Kuo TL; Chen YW; Kuo KK; Cheng KH
    Mol Cancer Res; 2013 Jul; 11(7):768-79. PubMed ID: 23552743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
    Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nestin is a novel target for suppressing pancreatic cancer cell migration, invasion and metastasis.
    Matsuda Y; Naito Z; Kawahara K; Nakazawa N; Korc M; Ishiwata T
    Cancer Biol Ther; 2011 Mar; 11(5):512-23. PubMed ID: 21258211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nestin delineates pancreatic cancer stem cells in metastatic foci of NOD/Shi-scid IL2Rγ(null) (NOG) mice.
    Matsuda Y; Yoshimura H; Ueda J; Naito Z; Korc M; Ishiwata T
    Am J Pathol; 2014 Mar; 184(3):674-85. PubMed ID: 24412093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX9 Triggers Different Epithelial to Mesenchymal Transition States to Promote Pancreatic Cancer Progression.
    Carrasco-Garcia E; Lopez L; Moncho-Amor V; Carazo F; Aldaz P; Collado M; Bell D; Gaafar A; Karamitopoulou E; Tzankov A; Hidalgo M; Rubio Á; Serrano M; Lawrie CH; Lovell-Badge R; Matheu A
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines.
    Tsubaki M; Komai M; Fujimoto S; Itoh T; Imano M; Sakamoto K; Shimaoka H; Takeda T; Ogawa N; Mashimo K; Fujiwara D; Mukai J; Sakaguchi K; Satou T; Nishida S
    J Exp Clin Cancer Res; 2013 Sep; 32(1):62. PubMed ID: 24011086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR7 regulates Twist to induce the epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
    Li K; Xu B; Xu G; Liu R
    Tumour Biol; 2016 Jan; 37(1):419-24. PubMed ID: 26219899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACTR3 promotes cell migration and invasion by inducing epithelial mesenchymal transition in pancreatic ductal adenocarcinoma.
    Hu H; Zhang S; Xiong S; Hu B; He Y; Gu Y
    J Gastrointest Oncol; 2021 Oct; 12(5):2325-2333. PubMed ID: 34790395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Interaction Between Long Non-coding RNA HULC and MicroRNA-622 via Transfer by Extracellular Vesicles Regulates Cell Invasion and Migration in Human Pancreatic Cancer.
    Takahashi K; Koyama K; Ota Y; Iwamoto H; Yamakita K; Fujii S; Kitano Y
    Front Oncol; 2020; 10():1013. PubMed ID: 32656089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer.
    Hotz B; Arndt M; Dullat S; Bhargava S; Buhr HJ; Hotz HG
    Clin Cancer Res; 2007 Aug; 13(16):4769-76. PubMed ID: 17699854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nestin and other putative cancer stem cell markers in pancreatic cancer.
    Matsuda Y; Kure S; Ishiwata T
    Med Mol Morphol; 2012 Jun; 45(2):59-65. PubMed ID: 22718289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDB2 represses epithelial-to-mesenchymal transition and sensitizes pancreatic ductal adenocarcinoma cells to chemotherapy.
    Dardare J; Witz A; Betz M; Francois A; Meras M; Lamy L; Lambert A; Grandemange S; Husson M; Rouyer M; Demange J; Merlin JL; Harlé A; Gilson P
    Front Oncol; 2022; 12():1052163. PubMed ID: 36568213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of the epithelial mesenchymal transition factors Snail, Slug, Twist, TGF-β, and E-cadherin in ameloblastoma.
    Kurioka K; Wato M; Iseki T; Tanaka A; Morita S
    Med Mol Morphol; 2017 Jun; 50(2):68-75. PubMed ID: 27995335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of overexpression of nestin with expression of epithelial-mesenchymal transition-related proteins in gastric adenocarcinoma.
    Liu JK; Chen WC; Ji XZ; Zheng WH; Han W; An J
    Asian Pac J Cancer Prev; 2015; 16(7):2777-83. PubMed ID: 25854362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.
    Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T
    Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
    Meng F; Li W; Li C; Gao Z; Guo K; Song S
    Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100 calcium-binding protein A6 promotes epithelial-mesenchymal transition through β-catenin in pancreatic cancer cell line.
    Chen X; Liu X; Lang H; Zhang S; Luo Y; Zhang J
    PLoS One; 2015; 10(3):e0121319. PubMed ID: 25799022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginine deprivation inhibits pancreatic cancer cell migration, invasion and EMT via the down regulation of Snail, Slug, Twist, and MMP1/9.
    Wang H; Li QF; Chow HY; Choi SC; Leung YC
    J Physiol Biochem; 2020 Feb; 76(1):73-83. PubMed ID: 31823303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of SNAIL in accompanying PanIN is a key prognostic indicator in pancreatic ductal adenocarcinomas.
    Fujiwara S; Saiki Y; Ishizawa K; Fukushige S; Yamanaka M; Sato M; Ishida M; Motoi F; Unno M; Horii A
    Cancer Med; 2019 Apr; 8(4):1671-1678. PubMed ID: 30791220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.